Browsing Category

Insights

feature image

SwipeRx Survey: Drug Pricing and the Use of Medication Samples in Malaysia

Malaysia’s Health Minister. Dr. Dzulkefly Ahmad, announced recently that the government was drafting a proposal to control the prices of drugs in the country. This medication pricing mechanism would guarantee that access to medicine is affordable for all citizens. What do pharmacy professionals think about it? How will it impact their patients? To find out, we ran a poll on SwipeRx, the largest social network of pharmacies and pharmacy professionals in Southeast Asia. We also took the opportunity to ask pharmacists about the use of medication samples across the practice. Scroll down to download our infographic. Majority of patients very concerned

for-mClinica-Pill-Box-Data-Survey-Image

Data: Most pharmacists in the Philippines agree with lowering CPD requirements

The Professional Regulation Commission (PRC) of the Philippines has recently decided to lower the Continuing Professional Development (CPD) requirements for pharmacists from 45 units to 15. Using our SwipeRx platform, we surveyed over 400 pharmacy professionals in the Philippines to ask them whether or not they were in favor of minimizing the CPD requirements. Read on to find out what our results showed: Overwhelming majority of pharmacists are in favor of the new CPD law Our poll revealed that more than 92% of pharmacists are in favor of reducing the required CPD units. The main reasons given were that it

dispensing antibiotics

New data: 1 out of 4 pharmacy professionals in Vietnam improperly dispense antibiotics

One of the greatest threats to global public health today is the rise of antimicrobial resistance (AMR). AMR is the ability of a microbe to resist the effects of medicine used to treat it. AMR is caused by the improper use of antibiotics  and is a rising concern in Southeast Asia because many patients are able to buy antibiotics without a prescription. Last month we polled over 400 pharmacy professionals in Vietnam to uncover pharmacists’ current practices in dispensing antibacterial drugs. What we found was consistent with our findings from other Southeast Asian countries, like the Philippines and Indonesia, and highlights the seriousness of the AMR

drug recalls

New data: Most pharmacists in Indonesia lack training for drug recalls

Multiple hypertension drugs including Irbesartan, Losartan, and Valsartan, have been recalled in the United States and Europe due to chemical impurities. Following the US and Europe’s lead, the National Agency for Drug and Food Control of the Republic of Indonesia (BPOM) has also ordered their recall.  At mClinica, we wanted to find out whether pharmacists in Indonesia are prepared to execute this drug recall. So, last month we polled 492 pharmacy professionals in Indonesia using SwipeRx surveys, and uncovered the following data: Most pharmacists knew about the recall but did not have training on how to respond According to our poll,

Is it real of fake medicine?

Why are fake medicines still a problem in Southeast Asia?

The problem of fake medicines is far from being solved in Asia. The Pharmaceutical Security Institute reported that 1,100 “incidents” involving counterfeit and illegal pharmaceuticals were reported in Asia in 2015. The UN Office on Drugs and Crime has also revealed that Asia has the largest share of the global trade in illegal and fake medicines. So, why does this problem persist and what solutions exist today? Failure to monitor the supply chain keeps fake medicines on the market When supply chain security is weak, it becomes increasingly difficult to trust that patients are being prescribed real medications. Recent crackdowns on counterfeit